A case report of cimetidine-induced clozapine toxicity. 1991

S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
Psychiatric Research Department, Hillside Hospital, Glen Oaks, NY 11004.

Cimetidine may decrease concomitant medication clearance by inhibiting the oxidative system of cytochrome P-450. The authors report increased serum clozapine levels and adverse side effects during clozapine and cimetidine treatment but not during clozapine and ranitidine treatment in a patient with chronic paranoid schizophrenia.

UI MeSH Term Description Entries
D008297 Male Males
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid

Related Publications

S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
January 2020, Frontiers in psychiatry,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
January 2023, SAGE open medical case reports,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
May 2020, International journal of clinical pharmacology and therapeutics,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
November 2021, Psychiatry research,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
January 2023, Revista Colombiana de psiquiatria (English ed.),
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
June 2021, Revista Colombiana de psiquiatria (English ed.),
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
January 2014, The primary care companion for CNS disorders,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
April 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
February 2022, Schizophrenia research,
S Szymanski, and J A Lieberman, and D Picou, and S Masiar, and T Cooper
February 2023, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
Copied contents to your clipboard!